| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
32,350,000 |
| Market
Cap: |
5.85(B) |
| Last
Volume: |
224,965 |
Avg
Vol: |
123,237 |
| 52
Week Range: |
$140.3 - $178.68 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Balchem is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Co. has three segments: Human Nutrition and Health, which provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from Co.'s microencapsulation and chelation technologies in addition to basic choline chloride; and Specialty Products, which distributes ethylene oxide, propylene oxide and ammonia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
1,200 |
1,200 |
133,664 |
| Total Sell Value |
$0 |
$185,328 |
$185,328 |
$20,954,717 |
| Total People Sold |
0 |
1 |
1 |
8 |
| Total Sell Transactions |
0 |
1 |
1 |
14 |
| End Date |
2025-11-16 |
2025-08-15 |
2025-02-14 |
2024-02-15 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Van Gunsteren Job Leonard |
SVP and GM, Specialty Products |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$10,294 |
D/D |
(58) |
10,149 |
|
- |
|
| Boned Frederic |
SVP/GM, Human Nutri. & Health |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$36,030 |
D/D |
(203) |
8,978 |
|
- |
|
| Tignor Michael Brent |
SVP & Chief HR Officer |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$29,286 |
D/D |
(165) |
10,723 |
|
- |
|
| Bengtsson Carl Martin |
EVP & Chief Financial Officer |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$53,602 |
D/D |
(302) |
27,926 |
|
- |
|
| Miyata Hatsuki |
EVP, CLO, & Secretary |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$32,126 |
D/D |
(181) |
8,745 |
|
- |
|
| Harris Theodore L |
Chairman, President & CEO |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$149,802 |
D/D |
(844) |
91,373 |
|
- |
|
| Reid Martin Luther |
SVP Chief Supply Chain Officer |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$20,589 |
D/D |
(116) |
9,073 |
|
- |
|
| Backus William A. |
VP & Chief Accounting Officer |
• • – |
2026-02-12 |
4 |
D |
$177.49 |
$12,424 |
D/D |
(70) |
6,736 |
|
- |
|
| Van Gunsteren Job Leonard |
SVP and GM, Specialty Products |
• • – |
2026-02-11 |
4 |
D |
$178.68 |
$135,082 |
D/D |
(756) |
10,207 |
|
- |
|
| Van Gunsteren Job Leonard |
SVP and GM, Specialty Products |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,775 |
10,963 |
|
- |
|
| Boned Frederic |
SVP/GM, Human Nutri. & Health |
• • – |
2026-02-11 |
4 |
D |
$178.68 |
$205,661 |
D/D |
(1,151) |
9,181 |
|
- |
|
| Boned Frederic |
SVP/GM, Human Nutri. & Health |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,117 |
10,332 |
|
- |
|
| Graham George |
SVP and Chief R&D Officer |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
3,200 |
|
- |
|
| Wineinger Matthew David |
|
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
870 |
8,012 |
|
- |
|
| Fischer David B |
|
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
870 |
8,859 |
|
- |
|
| Rigaud Olivier |
|
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
870 |
2,390 |
|
- |
|
| Tignor Michael Brent |
SVP & Chief HR Officer |
• • – |
2026-02-11 |
4 |
D |
$178.68 |
$177,072 |
D/D |
(991) |
10,888 |
|
- |
|
| Tignor Michael Brent |
SVP & Chief HR Officer |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,129 |
11,879 |
|
- |
|
| Bengtsson Carl Martin |
EVP & Chief Financial Officer |
• • – |
2026-02-11 |
4 |
D |
$178.68 |
$431,691 |
D/D |
(2,416) |
28,228 |
|
- |
|
| Bengtsson Carl Martin |
EVP & Chief Financial Officer |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,328 |
30,644 |
|
- |
|
| Miyata Hatsuki |
EVP, CLO, & Secretary |
• • – |
2026-02-11 |
4 |
D |
$178.68 |
$156,702 |
D/D |
(877) |
8,926 |
|
- |
|
| Miyata Hatsuki |
EVP, CLO, & Secretary |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,957 |
9,803 |
|
- |
|
| Harris Theodore L |
Chairman, President & CEO |
• • – |
2026-02-11 |
4 |
D |
$178.68 |
$1,672,087 |
D/D |
(9,358) |
92,217 |
|
- |
|
| Harris Theodore L |
Chairman, President & CEO |
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,641 |
101,575 |
|
- |
|
| Knutson Daniel E |
|
• • – |
2026-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
870 |
6,899 |
|
- |
|
362 Records found
|
|
Page 1 of 15 |
|
|
3.32 (1.87%) 
